- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03918863
Neuromuscular Electrical Stimulation on Patellofemoral Pain
October 19, 2019 updated by: Jamilson Simões Brasileiro, Universidade Federal do Rio Grande do Norte
Effects of a Neuromuscular Electrical Stimulation Protocol in Women With Patellofemoral Pain
Objective this study is to analyze the effects of an intervention protocol with neuromuscular electrical stimulation in the vastus medialis obliquus and gluteus medius (GM) associated with exercises on electromyographic activity, muscle performance, self-reported functionality and pain of women with patellofemoral pain.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This is a randomized, blinded trial in which 40 women, aged 18-30 years, will be randomized into 2 groups: Stimulation and Exercise Group (SEG) - will perform an exercise protocol associated with stimulation in the vastus medialis (VM) and gluteus medius (GM) muscles.
Exercises Group (ExG) - will perform the same protocol of exercises of the previous group, however, without association with neuromuscular electrical stimulation.
The intervention will occur twice a week for eight weeks.
All volunteers will be submitted to the evaluation of the electromyographic activity of the VM, the GM and the vastus lateralis, the dynamometric parameters, the intensity of the pain and the functionality, in four moments: 72h hours before the beginning of the intervention; after 4 weeks of intervention; after 8 weeks of intervention; after 16 weeks from the start of the intervention (eight weeks after the end of the protocol).
In this way, the investigators will investigate the applicability of the proposed trial with the use of neuromuscular electrical stimulation and identify the effects of this resource in the treatment of PFP.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
RN
-
Natal, RN, Brazil, 59140-840
- Recruiting
- Federal University of Rio Grande do Norte
-
Contact:
- Jamilson S Brasileiro, PhD
- Phone Number: +55 84 3342-2008
- Email: brasileiro@ufrnet.br
-
-
Rio Grande Do Norte
-
Natal, Rio Grande Do Norte, Brazil, 59078-970
- Recruiting
- Universidade Federal do Rio Grande do Norte
-
Contact:
- Jamilson Simões Brasileiro, PhD
- Phone Number: +55 84 3342-2008
- Email: brasileiro@ufrnet.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Present anterior or retropatellar pain during at least two of the following functional activities: sitting for long periods, going up or down stairs, running, kneeling down, crouching or jumping;
- A minimum pain score of three on the numerical pain scale, at the last 24 hours, with insidious and non-traumatic onset of symptoms for at least one month.
Exclusion Criteria:
- History of surgery, trauma or an osteomioarticular system injury in the lower limbs in the last six months;
- Other pathology associated with the knee joint and could not have performed physical therapy treatment in the last twelve weeks;
- Body mass index greater than 30;
- Pregnancy or breastfeeding;
- Contraindications for the application of neuromuscular electrical stimulation;
- Intolerance or non-acceptance of electric current;
- Missing more than two intervention sessions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neuromuscular electrical stimulation
8-week exercise program, twice a week, with neuromuscular eletrical stimulation on vastus medialis and gluteus medius.
|
Exercise protocol associated with neuromuscular electrical stimulation on vastus medialis and gluteus medius.
Parameters: rectangular pulse shape, biphasic, symmetrical, pulse duration of 200μs, interbust interval of 10ms and frequency of 2.500Hz modulated in 50 bursts.
Other Names:
|
|
Active Comparator: Exercise
8-week exercise program, twice a week.
|
Same protocol of exercises of the other group, without association of electrical stimulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee pain
Time Frame: Change from baseline in knee pain at 8 weeks.
|
Evaluation of pain level in the knee using the Numerical Pain Scale, graded from 0 to 10, where 0 indicates absence of pain and 10 indicates the worst pain imaginable.
|
Change from baseline in knee pain at 8 weeks.
|
|
Knee function
Time Frame: Change from baseline in knee function at 8 weeks.
|
Evaluation of knee function using the Anterior Knee Pain Scale, that is a questionnaire encompassing 13 items related to different levels of knee function, with scores ranging from zero (representing the highest possible deficit) to 100 (meaning that the subject does not present any deficit).
|
Change from baseline in knee function at 8 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Root Mean Square (RMS)
Time Frame: Change from baseline in RMS at 8 weeks.
|
Evaluation of the amplitude oh the electromyographic sinal (RMS) of vastus medialis, vastus lateralis and gluteus medius.
|
Change from baseline in RMS at 8 weeks.
|
|
Time of muscle activation (Onset)
Time Frame: Change from baseline in onset of the electromyographic at 8 weeks.
|
Evaluation of time of muscle activation electromyographic (onset) of vastus medialis, vastus lateralis and gluteus medius.
|
Change from baseline in onset of the electromyographic at 8 weeks.
|
|
Isokinetic performance
Time Frame: Change from baseline in peak torque normalized for body weight at 8 weeks.
|
Evaluation of isokinetic variable peak torque normalized for body weight (%) of knee extensors and hip abductors.
|
Change from baseline in peak torque normalized for body weight at 8 weeks.
|
|
Isokinetic performance
Time Frame: Change from baseline in average peak torque at 8 weeks.
|
Evaluation of isokinetic variable average peak torque (Nm) of knee extensors and hip abductors.
|
Change from baseline in average peak torque at 8 weeks.
|
|
Isokinetic performance
Time Frame: Change from baseline in average power at 8 weeks.
|
Evaluation of isokinetic variable average power (W) of knee extensors and hip abductors.
|
Change from baseline in average power at 8 weeks.
|
|
Isokinetic performance
Time Frame: Change from baseline in total work at 8 weeks.
|
Evaluation of isokinetic variable total work (J) of knee extensors and hip abductors.
|
Change from baseline in total work at 8 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jamilson S Brasileiro, PhD, Universidade Federal do Rio Grande do Norte
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 24, 2019
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
April 2, 2019
First Submitted That Met QC Criteria
April 16, 2019
First Posted (Actual)
April 18, 2019
Study Record Updates
Last Update Posted (Actual)
October 22, 2019
Last Update Submitted That Met QC Criteria
October 19, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAM2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patellofemoral Pain Syndrome
-
University of North Carolina, Chapel HillCanadian Institutes of Health Research (CIHR)CompletedPatellofemoral Pain Syndrome | Patellofemoral Pain (PFPS) | Patellofemoral Pain | Patellofemoral Pain, PFPUnited States
-
Lauren EricksonAmerican College of Sports MedicineCompleted
-
Beijing Sport UniversityCompletedPatellofemoral PainChina
-
Boston Children's HospitalEnrolling by invitationPatellofemoral PainUnited States
-
Beijing Sport UniversityNot yet recruitingPatellofemoral Pain, PFP
-
Beijing Sport UniversityNot yet recruiting
-
Istanbul University - CerrahpasaRecruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Ahram Canadian UniversityNot yet recruitingPatellofemoral Pain (PFPS)Egypt
-
Beijing Sport UniversityCompletedPatellofemoral Pain, PFPChina
Clinical Trials on Neuromuscular electrical stimulation
-
Brooks RehabilitationTerminatedBlepharoptosis | LagophthalmosUnited States
-
Necmettin Erbakan UniversityCompletedCerebral Palsy (CP)Turkey (Türkiye)
-
University Hospital, BrestCompletedAsthma | Chronic Obstructive Pulmonary Disease Overlap SyndromeFrance
-
Hacettepe UniversityCompleted
-
Universidade Federal do Rio Grande do NorteNot yet recruitingHeart Failure | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Kinesiophobia | Neuromuscular Electrical Stimulation (NMES)Brazil
-
MetroHealth Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedStroke | Hemiparesis | FootdropUnited States
-
Ambra BisioUniversita degli Studi di GenovaActive, not recruiting
-
Hopital ForcillesNot yet recruitingDysphagia | NeuroMuscular Electrical Stimulation
-
University of Sao PauloSuspendedRehabilitation | Critical CareBrazil